Predicta Biosciences

formerly Predicta

Unlocking Molecular Insights for Blood Cancer Care

Predicta Biosciences was founded in 2023, is headquartered in Cambridge, United States, lists 1–10 employees, and has $28.6M in recorded funding across 2 rounds.

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$28.6M
Last Round
$23.4M Series AOct 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 7 investors for this company. The full record is or through the API.

About

Predicta Biosciences is a Cambridge, MA-based precision oncology company that integrates multi-omics and liquid biopsy diagnostics to transform the diagnosis, monitoring, and treatment of blood cancers. From a single blood draw, its GenoPredicta platform delivers whole-genome sequencing of circulating tumor cells to uncover structural variants and clonal evolution that standard tests miss, while ImmunoPredicta adds single-cell immune profiling. The company also partners with biopharma firms for biomarker discovery, patient stratification, and clinical trial acceleration.

Summary

Predicta Biosciences is an Artificial Intelligence company based in Cambridge, United States, founded in 2023. It lists 1–10 employees. It has raised $28.6M in total across 2 rounds, most recently a $23.4M Series A round in Oct 2025. Investors include Engine Ventures, The Engine and Illumina Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2025
$23.4M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Predicta Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/predicta-biosciences"><img src="https://indexed.vc/api/badge/company/predicta-biosciences" alt="Predicta Biosciences on Indexed.vc" width="260" height="76" /></a>